ESCRS Showcase

Article

Some of the products that company's will shoiwcase at this year's ESCRS.

Corneal protection

CROMA will focus on the protection of the corneal surface during and after surgery. Hydration and protection of the cornea during surgical procedures are achieved with CORNEA_PROTECT® sterile single-dose units. HYLO-CARE® is a preservative-free therapeutic combination of sodium hyaluronate and dexpanthenol for the hydration and support of an enhanced healing process of the epithelium.

CROMA is performing research in the field of biomolecules and has developed the THIOMERS, a unique technology combining macromolecules, such as hyaluronic acid, with human amino acid (cysteine) for novel ophthalmic applications. In the field of dry eye, the THIOMER-based biopolymers will be able to covalently bind to the corneal surface and form a protective layer for more than 22 hours. This technology will be presented during CROMA´s satellite symposium.

What's new in retina

SLT in review of a decade

The introduction of Selective Laser Trabeculoplasty (SLT) represented the first fundamental change in laser treatment for open-angle glaucoma in many years. Following a decade of scientific and clinical experience, Lumenis has gathered a team of leading experts to discuss and debate the role of this unique technology. The faculty will address topics such as the current role of SLT in glaucoma management, how and when to apply the technology, patient selection and success predictors, long-term efficacy, repeatability, the most up-to-date clinical treatment protocol to ensure successful outcomes, and more.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
© 2025 MJH Life Sciences

All rights reserved.